http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#Head http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#assertion http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#provenance http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#pubinfo http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#assertion http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object https://identifiers.org/MONDO:0006966 http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/CHEBI:2619 http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association http://www.w3.org/2000/01/rdf-schema#label Amantadine hydrochloride capsules are indicated in the treatment of idiopathic Parkinson’s disease (Paralysis Agitans), postencephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication. It is indicated in those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis.It is indicated in those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis. http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#cohort http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association https://w3id.org/biolink/vocab/provided_by NeuroDKG http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association https://w3id.org/biolink/vocab/publications https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=491aea85-5a55-4a7c-b1cf-a123fea4377d http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#cohort http://www.w3.org/2000/01/rdf-schema#label elderly patients http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#cohort https://w3id.org/biolink/vocab/has_phenotype https://identifiers.org/MONDO:0006694 https://identifiers.org/CHEBI:2619 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug https://identifiers.org/MONDO:0006966 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#provenance http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#pubinfo http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#sig http://purl.org/nanopub/x/hasSignature LGZ3zDLZ6+fu/C8gWSTUOq2viZq037BYvS8qMo3y/sjL9W0k3vrF4TKMZbSviWSclxgc/opKcwnzqNgOYA6x8fQNZ+kDsqIzM3Pps4gJmZ8pJZuGO/lutVYtbwYjUMIU39U/gp+rWBVpti2XxwqEpsNzu9dBn0QS8c3QnASxLzw= http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk http://purl.org/dc/terms/created 2021-03-23T20:12:35.755+01:00 http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA8nK1kh1RiuFaqP-RHp2tpAeYCfxufGdy9GZpk3-8LLk https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RA59AEpaWRaR9sjdA0-n4zaQWdiZ6--iGafMrjrDAOheI